4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione,
TDZD-8,
thiadiazolidinone-8,
TDZD-8,
327036-89-5,
4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione,
GSK-3beta Inhibitor I,
TDZD 8,
MFCD04973552,
NP 01139,
1,2,4-Thiadiazolidine-3,5-dione, 2-methyl-4-(phenylmethyl)-,
AK-48153,
4-Benzyl-2-methyl-[1,2,4]thiadiazolidine-3,5-dione,
1,2,4-Thiadiazolidine-3,5-dione,2-methyl-4-(phenylmethyl)-,
GSK-3|A Inhibitor I,
GSK-3 Inhibitor I,
SCHEMBL139834,
BDBM7781,
CHEMBL284861,
GTPL5977,
CTK4G9152,
ZINC27361,
AOB6176,
DTXSID30399590,
EX-A109,
JDSJDASOXWCHPN-UHFFFAOYSA-N,
HMS3229G12,
GSK-3|A Inhibitor I, TDZD-8,
AC1N4739,
BCP07657,
KS-00000NY6,
Thiadiazolidinone (TDZD) deriv. 8,
ANW-66442,
HSCI1_000174,
s2926,
AKOS016004653,
CCG-206841,
CS-1671,
FCH1683080,
FS-2551,
RL03171,
NCGC00165913-01,
NCGC00165913-02,
NCGC00165913-03,
TDZD-8, >=98% (HPLC), needles,
4CA-1220,
AJ-08460,
BC600556,
HY-11012,
SC-96669,
ZB000810,
AB0035965,
DB-068679,
TC-155187,
B4436,
FT-0662841,
Y0470,
A11941,
S-7740,
TDZD-8; GSK-3|A Inhibitor I; NP 01139,
J-018843,
J-514480,
BRD-K45685959-001-02-7,
2-methyl-4-(phenylmethyl)-1,2,4-thiadiazolidine-3,5-dione,
thiadiazolidinone-8,
D06KNK,
NP12,
cc-646,
C10H10N2O2S,
CID4124851,
B1249,
C494356,
1,2,4-Thiadiazolidine-3,5-dione,2-Methyl-4-(phenylMethyl)-;,